These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 12620148)

  • 1. Phase I/IIA randomized study of PHY906, a novel herbal agent, as a modulator of chemotherapy in patients with advanced colorectal cancer.
    Farrell MP; Kummar S
    Clin Colorectal Cancer; 2003 Feb; 2(4):253-6. PubMed ID: 12620148
    [No Abstract]   [Full Text] [Related]  

  • 2. A phase I study of the chinese herbal medicine PHY906 as a modulator of irinotecan-based chemotherapy in patients with advanced colorectal cancer.
    Kummar S; Copur MS; Rose M; Wadler S; Stephenson J; O'Rourke M; Brenckman W; Tilton R; Liu SH; Jiang Z; Su T; Cheng YC; Chu E
    Clin Colorectal Cancer; 2011 Jun; 10(2):85-96. PubMed ID: 21859559
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prognostic factors for tumour response, progression-free survival and toxicity in metastatic colorectal cancer patients given irinotecan (CPT-11) as second-line chemotherapy after 5FU failure. CPT-11 F205, F220, F221 and V222 study groups.
    Freyer G; Rougier P; Bugat R; Droz JP; Marty M; Bleiberg H; Mignard D; Awad L; Herait P; Culine S; Trillet-Lenoir V
    Br J Cancer; 2000 Aug; 83(4):431-7. PubMed ID: 10945486
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Application and recent research progress of irinotecan in treatment of advanced colorectal cancer].
    Guan ZZ
    Zhonghua Zhong Liu Za Zhi; 2006 Sep; 28(9):718-9. PubMed ID: 17274384
    [No Abstract]   [Full Text] [Related]  

  • 5. Irinotecan may extend survival in people with metastatic colorectal cancer.
    Oncology (Williston Park); 1998 Oct; 12(10):1512. PubMed ID: 9798204
    [No Abstract]   [Full Text] [Related]  

  • 6. Capecitabine and irinotecan as first-line treatment of advanced colorectal cancer.
    Punt CJ; Koopman M
    J Clin Oncol; 2008 Apr; 26(11):1907-8; author reply 1908-9. PubMed ID: 18398161
    [No Abstract]   [Full Text] [Related]  

  • 7. [Management of chemotherapy induced diarrhea].
    Schultz M; Schölmerich J; Kullmann F
    Z Gastroenterol; 2004 Jun; 42(6):527-38. PubMed ID: 15190449
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chemotherapy of metastatic colorectal cancer: fluorouracil plus folinic acid and irinotecan or oxaliplatin.
    Prescrire Int; 2005 Dec; 14(80):230-3. PubMed ID: 16400749
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prospective, double-blind, placebo-controlled, multicenter, randomized phase III study with orally administered budesonide for prevention of irinotecan (CPT-11)-induced diarrhea in patients with advanced colorectal cancer.
    Karthaus M; Ballo H; Abenhardt W; Steinmetz T; Geer T; Schimke J; Braumann D; Behrens R; Behringer D; Kindler M; Messmann H; Boeck HP; Greinwald R; Kleeberg U
    Oncology; 2005; 68(4-6):326-32. PubMed ID: 16020959
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neomycin as secondary prophylaxis for irinotecan-induced diarrhea.
    Schmittel A; Jahnke K; Thiel E; Keilholz U
    Ann Oncol; 2004 Aug; 15(8):1296. PubMed ID: 15277273
    [No Abstract]   [Full Text] [Related]  

  • 11. Phase II clinical trial for prevention of delayed diarrhea with cholestyramine/levofloxacin in the second-line treatment with irinotecan biweekly in patients with metastatic colorectal carcinoma.
    Flieger D; Klassert C; Hainke S; Keller R; Kleinschmidt R; Fischbach W
    Oncology; 2007; 72(1-2):10-6. PubMed ID: 17998785
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Chemotherapy-induced diarrhea].
    Kobayashi K
    Gan To Kagaku Ryoho; 2003 Jun; 30(6):765-71. PubMed ID: 12852342
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Double-blind, placebo-controlled, randomized phase II study of TJ-14 (Hangeshashinto) for infusional fluorinated-pyrimidine-based colorectal cancer chemotherapy-induced oral mucositis.
    Matsuda C; Munemoto Y; Mishima H; Nagata N; Oshiro M; Kataoka M; Sakamoto J; Aoyama T; Morita S; Kono T
    Cancer Chemother Pharmacol; 2015 Jul; 76(1):97-103. PubMed ID: 25983022
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Irinotecan plus weekly 5-fluorouracil and leucovorin as salvage treatment for patients with metastatic colorectal cancer: a phase II trial.
    Souglakos J; Vardakis N; Androulakis N; Kakolyris S; Kourousis C; Mavroudis D; Pallis A; Agelaki S; Kalbakis K; Georgoulias V
    Dig Dis; 2007; 25(1):100-5. PubMed ID: 17384515
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Phase II study of FOLFIRI regimen in patients with advanced colorectal cancer refractory to fluoropyrimidine and oxaliplatin.
    Bao HY; Fang WJ; Zhang XC; Shi GM; Huang S; Yu LF; Chen J; Mou HB; Deng J; Shen P; Xu N
    Cancer Chemother Pharmacol; 2011 Jan; 67(1):147-52. PubMed ID: 20221830
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Integration of novel agents in the treatment of colorectal cancer.
    Iqbal S; Lenz HJ
    Cancer Chemother Pharmacol; 2004 Sep; 54 Suppl 1():S32-9. PubMed ID: 15309512
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy of prophylactic anti-diarrhoeal treatment in patients receiving Campto for advanced colorectal cancer.
    Duffour J; Gourgou S; Seitz JF; Senesse P; Boutet O; Castera D; Kramar A; Ychou M
    Anticancer Res; 2002; 22(6B):3727-31. PubMed ID: 12552984
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Targeting vascular endothelial growth factor in colorectal cancer.
    Berlin JD
    Oncology (Williston Park); 2002 Aug; 16(8 Suppl 7):13-5. PubMed ID: 12199627
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Irinotecan plus fluorouracil and leucovorin for metastatic colorectal cancer.
    Pestalozzi BC
    N Engl J Med; 2001 Jan; 344(4):306; author reply 306-7. PubMed ID: 11191662
    [No Abstract]   [Full Text] [Related]  

  • 20. [Irinotecan plus fluorouracil and folinic acid in metastatic colorectal cancer].
    Krieger G
    Strahlenther Onkol; 2001 Jun; 177(6):316-8. PubMed ID: 11446323
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.